GemPharmatech Co., Ltd. (SHA:688046)
China
· Delayed Price · Currency is CNY 11.60
-0.13 (-1.11%)
At close: May 23, 2025, 2:57 PM CST
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 4.73 billion as of May 23, 2025. Its market cap has decreased by -2.97% in one year.
Market Cap
4.73B
Enterprise Value
3.75B
Revenue
700.61M
Ranking
n/a
PE Ratio
42.96
Stock Price
11.60
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has decreased from 7.59B to 4.73B, a decrease of -37.69%. That is a compound annual growth rate of -14.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 4.73B | -9.96% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 366.93B |
| Shenzhen Mindray Bio-Medical Electronics | 272.84B |
| WuXi AppTec | 179.48B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.55B |
| Aier Eye Hospital Group | 117.89B |
| Shanghai United Imaging Healthcare | 112.34B |
| Sichuan Biokin Pharmaceutical | 111.48B |
| Yunnan Baiyao Group Co.,Ltd | 101.17B |